Iroquois Homeobox Protein 2 Identified as a Potential Biomarker for Parkinson’s Disease

Iroquois Homeobox Protein 2 Identified as a Potential Biomarker for Parkinson’s Disease

The diagnosis of Parkinson’s disease (PD) is initiated after the occurrence of motor symptoms, such as resting tremors, rigidity, and bradykinesia. According to previous reports, non-motor symptoms, notably gastrointestinal dysfunction, could potentially be early biomarkers in PD patients as such sy...

Full description

Bibliographic Details
Main Authors: Hyuna Sim, Joo-Eun Lee, Hee Min Yoo, Sunwha Cho, Hana Lee, Aruem Baek, Jisun Kim, Hyemyung Seo, Mi-Na Kweon, Hyung Gun Kim, Young-Joo Jeon, Mi-Young Son, Janghwan Kim
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:International Journal of Molecular Sciences
Subjects:
Parkinson’s disease
<i>LRRK2</i> G2019S
intestinal organoid
pluripotent stem cells
diagnostic marker
<i>IRX2</i>
Online Access:https://www.mdpi.com/1422-0067/21/10/3455

Internet

https://www.mdpi.com/1422-0067/21/10/3455

Similar Items